Quality of life, self-reported outcomes and impact of education among people with moderate and severe hemophilia A: An integrated perspective from a Latin American country
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287972 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Liliana Torres und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs, Bayer S.A., Bogotá, Colombia. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer.
Abstract (Originalsprache)
Collecting and interpreting self-reported outcomes among people with hemophilia A supports the understanding of the burden of the disease and its treatment to improve holistic care. However, in Colombia, this information is limited. Therefore, this study aimed to describe the knowledge, perception and burden of hemophilia A from the patients’ perspective. A cross-sectional study was conducted in the context of a hemophilia educational bootcamp held from November 29 th to December 1 st , 2019, in Medellin, Colombia. The bootcamp was organized by a hemophilia patient association responsible for contacting and inviting patients with hemophilia A (PwHA). Information on patients’ health beliefs, treatment experiences, and health-related quality of life (HRQoL) was obtained through focus groups, individual interviews and the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. A total of 25 moderate or severe PwHA were enrolled in this study and completed the PROBE questionnaire. Acute pain was the most frequently reported symptom, with 88% of the patients reporting the use of pain medication. Difficulty with activities of daily living was reported by 48%. Furthermore, 52% reported having more than 2 spontaneous bleeding events in the last year. Treatment was administered at home for 72% of patients, with regular prophylaxis as the most common treatment regimen. In terms of overall HRQoL, the median EQ-5D VAS score was 80 (IQR: 50–100). PwHA in Colombia still suffer from disease complications related to bleeding events, pain and disability that affect their HRQoL, which highlights the need to develop patient-centered initiatives to improve the wellness of this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical Affairs, Bayer S.A., Bogotá, Colombia.
- IPSOS Napoleon Franco S.A., Bogotá, Colombia.
- Bayer Pharmaceuticals, Sant Joan Despi, Spain.
ORCID-Profile: David Vizcaya, Juan-Sebastian Franco
Förderung
- Bayer
Zitieren
APA
Torres, L., Peñuela, O., Forero, M. D. R., Satizabal, J., Salazar, X., Benavides, D., Gamarra, R., Rivera, M., Vizcaya, D., & Franco, J. S. (2023). Quality of life, self-reported outcomes and impact of education among people with moderate and severe hemophilia A: An integrated perspective from a Latin American country. PLOS ONE. https://doi.org/10.1371/journal.pone.0287972
Vancouver
Torres L, Peñuela O, Forero MDR, Satizabal J, Salazar X, Benavides D, et al. Quality of life, self-reported outcomes and impact of education among people with moderate and severe hemophilia A: An integrated perspective from a Latin American country. PLOS ONE. 2023. doi:10.1371/journal.pone.0287972
BibTeX
@article{Torres2023,
author = {Torres, Liliana and Peñuela, Oscar and Forero, Maria Del Rosario and Satizabal, Juan and Salazar, Ximena and Benavides, Diana and Gamarra, Raul and Rivera, Marcela and Vizcaya, David and Franco, Juan-Sebastian},
title = {Quality of life, self-reported outcomes and impact of education among people with moderate and severe hemophilia A: An integrated perspective from a Latin American country},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287972}
}
EUVIMED